Gold has big year in 2020 and outlook for this year robust. Learn about monetary expansion and gold future prices.Read More
The gold futures price reached US$1,767/ounce this week before retreating, which was the second time it has surpassed US$1,760 in the past two months, marking some of gold's highest levels in several years.Read More
Following a mapping and prospecting campaign in conjunction with a grid-based soil sampling program and follow-up rock channel sampling, Carube Copper (TSXV: CUC) reported the discovery of high-grade copper-silver mineralization at its Main Ridge Project in Jamaica.Known for its initials MR, the project covers 30 square kilometres of the island country's south-central region, an area where the Spa...Read More
A retired Brazilian Army officer who recently advised Canadian miner Belo Sun (TSX: BSX) about its plans to mine gold in the Amazon, will head the country's Indigenous Rights Agency (Funai) aiming at using his experience in the sector to deal with hundreds of impending clashes between miners and locals.Native descendant General Franklimberg Ribeiro de Freitas had run Funai until April 2018, but wa...Read More
ROBOTIC TRADING GONE WILD (ROOMBA'S)I am a Market Maker. I represent Small Cap issues (.01-3.00) on Junior Canadian Exchanges. In simple terms, my role is to help establish an orderly Market for these Securities. I have great respect for the Corporations that pay me a fee to conduct my services on their behalf, which covers my associated costs and of course, risk. They d...Read More
I met Steve Leeb in 1980 while working at a Wall Street firm. I have always found Steve's analysis to be excellent. I would strongly suggest that you listen to the interview from the "King World News" website. You cannot afford to miss it.Dr. Stephen Leeb: Broadcast Interview - Available NowRead More
Import prices for stainless steel in Asia appear to have stabilized after a six-month slump thanks to an uptick in demand, a recovery in the nickel market and a potential drop in Indonesian supply. These seem to have put an end to the region's heated price war, sources told Fastmarkets MB on Wednesday January 16.Prices for 304 stainless cold-rolled coil and hot-rolled coil began to decline in earl...Read More
Positive U.S.-China trade headlines fueled the risk-on tradingStocks sailed into the long weekend with a big win, as a fresh batch of U.S.-China trade headlines fueled investors' appetite for risk -- and offset a negative earnings reaction for Netflix (NFLX). The Dow added more than 300 points as trade-sensitive Caterpillar (CAT) climbed and oil major Chevron (CVX) surged on a big bull note, while...Read More
HBI's rally into a historically bearish trendline could mark a selling opportunityThe shares of Hanesbrands Inc (NYSE:HBI) have rebounded sharply off their Dec. 24 five-year closing low of $11.62, up 27.7% since then to trade at $14.84. However, in its attempt at a comeback, the apparel name is now testing the waters around a key trendline -- sending up a potentially bearish signal that has has se...Read More
Weak fourth-quarter guidance means a new record low for CASAStocks are cruising into the long weekend on U.S-China trade talk optimism. Luxury retailer Tiffany & Co. (NYSE:TIF) is higher, while Bowflex parent Nautilus, Inc. (NYSE:NLS) and broadband network solutions provider Casa Systems Inc (NASDAQ:CASA) are sharply lower. Below, we'll take a look at what's moving the shares of TIF, NLS, and CASA...Read More
CIBC initiated coverage on the weed stock with an "outperform" ratingThe shares of Cronos Group Inc (NASDAQ:CRON) are red-hot today, after CIBC initiated coverage on the weed stock with an "outperform." The analyst in coverage waxed optimistic on the company's management team, and said it expects Cronos to withstand volatility in the growing industry. As a result, CRON stock is up 8.6% at $14.83,...Read More
Gold investment demandreversed sharply higher in recent months, fueling a strong gold rally. The big stock-market selloff rekindledinterest in prudently diversifying stock-heavy portfolios with counter-movinggold. These mounting investment-capitalinflows into gold are likely to persist and intensify. Both weaker stock markets and higher goldprices will continue to drive more inve...Read More
Positive news on U.S.-China relations helped stocks on FridayU.S. stocks rose this week thanks to upbeat trade developments, including Friday's bombshell report that China has offered to increase its U.S. imports over the next six years. Earlier in the week traders got a huge dose of earnings out of the financial sector, with mixed reactions throughout. At the time of this writing, the Dow Jones I...Read More
CloseGain/LossOn WeekGold $1280.70-$11.10-0.59%Silver$15.33-$0.20-1.73%XAU68.38-1.66%-4.64%HUI150.77-1.96%-5.41%GDM571.03-1.19%-3.24%JSE Gold1330.83-22.76-3.81%USD96.37+0.32+0.73%Euro113.66-0.25-0.90%Yen91.24-0.53-1.04%Oil$53.80+$1.73+4.28%10-Year2.787%+0.041+3.15%Bond144.46875-0.5625-0.88%Dow24706.35+1.38%+2.96%Nasdaq7157.23+1.03%+2.66%S&P2670.71+1.32%+2.87% The Metals: ...Read More
- History may repeat itself for gold demand and prices as world economy looks set to slow- Three reasons for gold's extended rally from 2008 to 2011 may be making a comeback- As global growth looks to be slowing, hopes grow for repeat of 2008-11 rally that saw gold almost triple in valueby Clyde Russell of Thomson ReutersThe three legs that supported gold's extended rally from just after the 2...Read More
Failure of gold to break and trade over $1304 by the 25th of January will result in fatigue and a fall to $1272 and $1256. This is just a technical view. However sharp dips should be used to invest with a trailing stop loss below $1230 for the end of April and a price target over $1410. The reason for the above cautious view (despite being very bullish on gold even at the current price of $129...Read More
Will 2019 be better than 2018 for the yellow metal? We invite you to read our today’s article, painting the macroeconomic outlook for 2018 and learn whether fundamental factors will become less or more friendly toward gold.What will 2019 be like? We do not know the precise answer, but we notice a few important economic trends that will shape the new year.1.Interest rates will continue to ris...Read More
How you can transform lagging indicators into leading indicators.With the market action of the last few weeks, some traders may feel like they're working blind -- after all, who knows what the Dow will do next? With bulls and bears butting heads in their predictions, many investors are looking for a way to try and predict what's to come, to avoid losing any of their capital to sudden corrections a...Read More
Early investors stand to reap the rewards as a new technology looks to change everything.One research firm - which recommended Google and Amazon before they became household names - has built a worldwide reputation of identifying profitable tech trends well before Wall Street and the talking heads on T.V.And just recently, they've uncovered a technology that's already being labeled "humanity's las...Read More
Our Adaptive Fibonacci modeling system is suggesting Crude Oil may have already reached very strong resistance levels just above $50 ppb. It is our opinion that a failed rally above $55 ppb will result in another downward price move where prices could retest the $42 low – or lower.You can see from this Daily Crude oil chart that price has formed a consolidated price channel between $50 and $...Read More
The S&P and Nasdaq are both headed for their fourth day in the blackThe Dow Jones Industrial Average (DJI) is set to finish the week strong, up 245 points at midday, as Wall Street celebrates positive progress in trade talks between the U.S. and China. Specifically, China has reportedly offered the U.S. a six-year increase in imports to $1 trillion per year, according to Bloomberg. Elsewhere, trad...Read More
Options volume is pacing for an annual high on both stocksThe shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) and Immunomedics, Inc. (NASDAQ:IMMU) are getting walloped this morning, as traders react to Food and Drug Administration (FDA) news. Specifically, LXRX is plunging after an FDA advisory panel was split (8-8) on whether to recommend approval of Lexicon's sotagliflozin, a type 1 diabet...Read More